Home Technology IbisVision unveils groundbreaking tech for fast online eye prescriptions.

IbisVision unveils groundbreaking tech for fast online eye prescriptions.

0
IbisVision unveils groundbreaking tech for fast online eye prescriptions.

Scotland-based company IbisVision has introduced a new over-the-internet eye care technology that allows optometrists to remotely determine a corrective lens prescription. The technology, called IbisConnect, utilizes a proprietary remote refraction tool and an intuitive interface to perform 11 different eye exams, expanding on the company’s existing internet platform. CEO Mark Roger expressed excitement about the potential for the technology to make eye care more accessible and to boost e-commerce within the optometry industry. The platform has various applications, including prescreening, contact lens checks, triage, and complete exams.

IbisVision’s new technology has been launched at Vision Expo West and has been well-received by eye care professionals. The platform offers a more accurate and remote method of performing visual field tests, which can be conducted by clinicians from anywhere. The technology is FDA-cleared, reimbursable, and is currently undergoing clinical trials. IbisVision CEO Mark Roger believes that the use of this technology has the potential to revolutionize the way eye care is delivered and improve accessibility for patients.

The launch of IbisVision’s over-the-internet eye care technology represents a significant breakthrough in the field. By allowing optometrists to remotely determine a corrective lens prescription, the technology has the potential to make eye care more accessible and convenient for patients. In addition, the use of this technology can significantly reduce the cost and investment required for traditional eye care equipment. The platform’s wide range of applications, including prescreening, contact lens checks, and complete exams, further highlight its versatility and potential impact on the optometry industry. With the technology currently undergoing clinical trials, it will be interesting to see how it shapes the future of eye care.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here